We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
NOV
NOV
$7.45B
| $6.12M | 0.08% |
275,504
-223,926
| -45% | -$5.41M |
|
302
Oracle
ORCL
$331B
| $6.12M | 0.08% |
107,340
+90,400
| +534% | +$4.89M |
|
303
TriNet
TNET
$2.84B
| $6.11M | 0.08% |
90,159
+5,710
| +7% | +$363K |
|
304
Valmont Industries
VMI
$9.44B
| $6.07M | 0.08% |
47,842
+33,539
| +234% | +$4.18M |
|
305
Howmet Aerospace
HWM
$116B
| $6.07M | 0.08% |
306,338
-225,371
| -42% | -$3.8M |
|
306
Barrett Business Services
BBSI
$976M
| $6.03M | 0.08% |
292,208
+6,960
| +2% | +$135K |
|
|
KYNB
307
Kyntra Bio
KYNB
$28.5M
| $6.02M | 0.08% |
+5,331
| New | +$5.83M |
|
308
Interactive Brokers
IBKR
$40.9B
| $6M | 0.08% |
442,888
-197,720
| -31% | -$2.68M |
|
309
Rayonier
RYN
$6.49B
| $6M | 0.08% |
218,204
+6,338
| +3% | +$177K |
|
310
Aecom
ACM
$9.07B
| $5.98M | 0.08% |
157,914
+43,034
| +37% | +$1.43M |
|
311
Matrix Service
MTRX
$347M
| $5.92M | 0.08% |
292,385
+32,880
| +13% | +$649K |
|
312
John Wiley & Sons Class A
WLY
$2.52B
| $5.76M | 0.08% |
+125,617
| New | +$5.71M |
|
313
OFG Bancorp
OFG
$2.21B
| $5.76M | 0.08% |
242,218
+47,810
| +25% | +$952K |
|
314
SPX Corp
SPXC
$11B
| $5.76M | 0.08% |
174,376
+106,580
| +157% | +$3.56M |
|
315
HUB Group
HUBG
$3.01B
| $5.72M | 0.08% |
272,568
+690
| +0.3% | +$14.5K |
|
316
Netflix
NFLX
$292B
| $5.7M | 0.08% |
+155,150
| New | +$5.6M |
|
317
American Homes 4 Rent
AMH
$12B
| $5.68M | 0.08% |
233,647
-12,200
| -5% | -$293K |
|
318
Wintrust Financial
WTFC
$10.7B
| $5.61M | 0.08% |
76,717
-2,040
| -3% | -$149K |
|
319
Nu Skin
NUS
$247M
| $5.6M | 0.08% |
113,605
-104,449
| -48% | -$5.31M |
|
320
ePlus
PLUS
$2.33B
| $5.57M | 0.08% |
161,638
+10,800
| +7% | +$449K |
|
|
CJ
321
DELISTED
C&J Energy Services, Inc.
CJ
| $5.56M | 0.08% |
472,036
+220,265
| +87% | +$3.02M |
|
322
Ironwood Pharmaceuticals
IRWD
$611M
| $5.56M | 0.08% |
+508,143
| New | +$5.69M |
|
323
Colgate-Palmolive
CL
$72.6B
| $5.53M | 0.08% |
77,100
-4,810
| -6% | -$341K |
|
324
Sherwin-Williams
SHW
$78.3B
| $5.5M | 0.08% |
+36,021
| New | +$5.38M |
|
325
Merck
MRK
$324B
| $5.46M | 0.08% |
68,183
+58,227
| +585% | +$4.46M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.